These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12200784)

  • 1. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
    Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
    Asaoka T; Kato T; Marubashi S; Dono K; Hama N; Takahashi H; Kobayashi S; Takeda Y; Takemasa I; Nagano H; Yoshida H; Ruiz P; Tzakis AG; Matsubara K; Monden M; Doki Y; Mori M
    Liver Transpl; 2009 Dec; 15(12):1738-49. PubMed ID: 19938108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
    Jain A; Ryan C; Mohanka R; Orloff M; Abt P; Romano J; Bryan L; Batzold P; Mantry P; Bozorgzadeh A
    Clin Transplant; 2006; 20(5):624-33. PubMed ID: 16968489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
    Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
    Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K; Miller C; Hirose K; Diago T; Aucejo F; Quintini C; Eghtesad B; Corey R; Yerian L; Lopez R; Zein N; Fung J
    Clin Transplant; 2010; 24(5):701-8. PubMed ID: 20047619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A; Molina E; Moura R; Bejarano PA; Khaled A; Ruiz P; Arheart K; Berho M; Drachenberg CB; Mendez P; O'Brien C; Jeffers L; Tzakis A; Schiff ER
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ; Aardema KL; Burd EM; Nakhleh RE; Brown KA; Abouljoud MS; Hirst K; Moonka DK
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation.
    MacQuillan GC; de Boer WB; Allan JE; Platten MA; Reed WD; Jeffrey GP
    Clin Transplant; 2010; 24(2):252-8. PubMed ID: 19712085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.
    Joshi D; Salehi S; Brereton H; Arno M; Quaglia A; Heaton N; O'Grady J; Agarwal K; Aluvihare V
    Liver Transpl; 2013 Apr; 19(4):383-94. PubMed ID: 23408392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
    Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Schmeding M; Kienlein S; Röcken C; Neuhaus R; Neuhaus P; Heidenhain C; Neumann UP
    Transpl Immunol; 2010 Aug; 23(4):156-60. PubMed ID: 20558292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
    Killackey MT; Gondolesi GE; Liu LU; Paramesh AS; Thung SN; Suriawinata A; Nguyen E; Roayaie S; Schwartz ME; Emre S; Schiano TD
    Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.